Prediction of factor VIII inhibitor development in the SIPPET cohort by mutational analysis and factor VIII antigen measurement
Silvia Spena, Isabella Garagiola, Antonino Cannavò, Mimosa Mortarino, P.M. Mannucci, Frits R. Rosendaal, Flora Peyvandi, Amal El‐Beshlawy, Mohsen Saleh Elalfy, Vijay Ramanan, Peyman Eshghi, Suresh Hanagavadi, Ramya Varadarajan, Milad Karimi, Mamta Manglani, Cecil Ross, George R. Young, Tulika Seth, Suneel Apte, Dinesh Nayak, Elena Santagostino, Maria Elisa Mancuso, Adriana C. Sandoval Gonzalez, Johnny Mahlangu, Santiago Bonanad, Marcos Cerqueira, Nadia P. Ewing, Christoph Male, Tarek Owaidah, Verónica Soto Arellano, Nathan L. Kobrinsky, S. S. Majumdar, Rosario Garrido, Anupam Sachdeva, Michael A. Simpson, Meenu Thomas, Ezio Zanon, Bülent Antmen, Kaan Kavaklı, Marilyn J. Manco‐Johnson, Miguel J. Martínez, E. Marzouka, M.G. Mazzucconi, Daniela Neme, A. Palomo Bravo, Rodrigo Aguilera, A. Prezotti, Katharina Schmitt, Brian M. Wicklund, Bülent Zülfikar (2018). Prediction of factor VIII inhibitor development in the SIPPET cohort by mutational analysis and factor VIII antigen measurement. Journal of Thrombosis and Haemostasis, 16(4), pp. 778-790, DOI: 10.1111/jth.13961.
